COVID-19 related mental health issues: a narrative review of psychometric properties of scales and methodological concerns in scale development.


Journal

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
ISSN: 1440-1665
Titre abrégé: Australas Psychiatry
Pays: England
ID NLM: 9613603

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 25 2 2021
medline: 9 6 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

The global crisis of COVID-19 and its consequential strict public health measures placed around the world have impacted mental health. New scales and tools have been developed to measure these mental health effects. This narrative review assesses the psychometric properties of these scales and tools and methodological aspects of their development. PubMed, PubMed Central, and Google Scholar were searched for articles published from 15 May 2020 to 15 August 2020. This search used three groups of terms ("tool" OR "scale" AND "mental" OR "psychological"; AND "COVID-19" OR "coronavirus"). The identified scales were further evaluated for their psychometric properties and methodological aspects of their development. Though the studies developing these scales ( The heterogeneous and inadequate reporting of methods adopted to evaluate the psychometric properties of the identified scales can limit their utility in clinical and research settings. We suggest developing guidelines and checklists to improve the design and testing, and result in reporting of online-administered scales to assess the mental health effects of the COVID-19 pandemic.

Identifiants

pubmed: 33626303
doi: 10.1177/1039856221992645
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

326-332

Auteurs

Ramdas Ransing (R)

Department of Psychiatry, BKL Walawalkar Rural Medical College, Ratnagiri, MH, India.

Elona Dashi (E)

Department of Neuroscience, University Hospital Center "Mother Theresa," Tirana, Albania.

Sajjadur Rehman (S)

Department of Psychiatry, Lady Hardinge Medical College, New Delhi, DL, India.

Varun Mehta (V)

Department of Psychiatry, Central Institute of Psychiatry, Kanke, Ranchi, JH, India.

Ashish Chepure (A)

Department of Psychiatry, Vilasrao Deshmukh Government Institute of Medical Sciences, Latur, Maharashtra, India.

Ozge Kilic (O)

Department of Psychiatry, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey.
Department of Psychiatry, Koç University Hospital, Topkapi, Istanbul, Turkey.

Nafisatu Hayatudeen (N)

Federal Neuropsychiatric Hospital, Kaduna, Kaduna State, Nigeria.

Laura Orsolini (L)

Department of Clinical Neurosciences/DIMSC, School of Medicine, Section of Psychiatry, Polytechnic University of Marche, Ancona, Italy.
Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Herts, UK.

Bita Vahdani (B)

Ministry of Health and Education, Tehran, Iran; Clinical research development unit, Qazvin University of Medical Sciences, Qazvin, Iran.

Frances Adiukwu (F)

Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers state, Nigeria.

Jairo M Gonzalez-Diaz (JM)

CERSAME School of Medicine and Health Sciences, Universidad del Rosario -Clínica Nuestra Señora de la Paz, Bogota, Colombia.

Amine Larnaout (A)

Razi Hospital, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

Mariana Pinto da Costa (M)

Unit for Social and Community Psychiatry, WHO Collaborating Centre for Mental Health Services Development, Queen Mary University of London, London, UK.
Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal.
Hospital de Magalhães Lemos, Porto, Portugal.

Paolo Grandinetti (P)

Addictions Service, Department of Territorial Services, Teramo, Italy.

Joan Soler-Vidal (J)

Fidmag Research Foundation, Hermanas Hospitalarias, Barcelona, Spain.
Hospital Benito Menni CASM, Hermanas Hospitalarias, Sant Boi de Llobregat, Barcelona, Spain.
Medicine and Traslational Research Doctorate Programme, University of Barcelona, Barcelona, Spain.

Drita Gashi Bytyçi (DG)

Hospital and University Clinical Service of Kosovo, Community Based Mental Health Center and House for Integration, Prizren, Kosovo.

Mohammadreza Shalbafan (M)

Mental Health Research Center, Department of Psychiatry, Iran University of Medical Sciences, Tehran, Iran.

Marwa Nofal (M)

Helwan Mental Health Hospital, Helwan, Cairo, Egypt.

Victor Pereira-Sanchez (V)

Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.

Rodrigo Ramalho (R)

Department of Social and Community Health, School of Population Health, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH